Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses
(Q33415400)
scientific article
scientific article
Language:
Current Data About
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses
other details
| description | scientific article |
External Links
| (P356) |
10.1093/JNCI/DJU089
|
| (P698) |
24842883
|
| (P932) |
4049120
|
| (P5875) |
262536784
|
| (P8608) |
release_bzvcngeefnf2hfjdwhikfz45dy
|